Discontinuation report CLINDAMYCIN INJECTION IN 5% DEXTROSE
| Report ID | 183710 |
| Drug Identification Number | 02485451 |
| Brand name | CLINDAMYCIN INJECTION IN 5% DEXTROSE |
| Common or Proper name | CLINDAMYCIN INJECTION IN 5% DEXTROSE (300mg/50mL) |
| Company Name | BAXTER CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CLINDAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50ml |
| ATC code | J01FF |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-04-01 |
| Actual discontinuation date | 2023-04-01 |
| Remaining supply date | 2023-04-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-04-02 | English | Compare |
| v2 | 2023-02-06 | French | Compare |
| v1 | 2023-02-06 | English | Compare |
Showing 1 to 3 of 3